These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept. Woo JH, Lee HJ, Sung IH, Kim TH. J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317 [Abstract] [Full Text] [Related]
23. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Braun J, Baraliakos X, Listing J, Sieper J. Arthritis Rheum; 2005 Aug; 52(8):2447-51. PubMed ID: 16052578 [Abstract] [Full Text] [Related]
24. Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept. Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J. J Rheumatol; 2004 Mar; 31(3):531-8. PubMed ID: 14994401 [Abstract] [Full Text] [Related]
25. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes? Kaya A, Ozgocmen S, Kamanli A, Ardicoglu O. Med Princ Pract; 2009 Mar; 18(6):470-6. PubMed ID: 19797924 [Abstract] [Full Text] [Related]
26. Body fat changes and activity of tumor necrosis factor α system--a 5-year follow-up study. Olszanecka-Glinianowicz M, Chudek J, Kocełak P, Szromek A, Zahorska-Markiewicz B. Metabolism; 2011 Apr; 60(4):531-6. PubMed ID: 20580040 [Abstract] [Full Text] [Related]
27. Association between bone mineral density (DXA), body structure, and body composition in middle-aged men. Van Langendonck L, Claessens AL, Lefevre J, Thomis M, Philippaerts R, Delvaux K, Lysens R, Vanden Eynde B, Beunen G. Am J Hum Biol; 2002 Apr; 14(6):735-42. PubMed ID: 12400034 [Abstract] [Full Text] [Related]
29. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M. Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169 [Abstract] [Full Text] [Related]
30. Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Allali F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C. Ann Rheum Dis; 2003 Apr; 62(4):347-9. PubMed ID: 12634235 [Abstract] [Full Text] [Related]
31. Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease. Bernstein M, Irwin S, Greenberg GR. Am J Gastroenterol; 2005 Sep; 100(9):2031-5. PubMed ID: 16128948 [Abstract] [Full Text] [Related]
32. [Effect of age on body composition in healthy Beijing women]. Chen R, Lin SQ, Lin X, Chen Y, Yang QH, Zhou Y, Zhang Y. Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):36-40. PubMed ID: 18366931 [Abstract] [Full Text] [Related]
33. Relationship between body composition and bone mineral density (BMD) in perimenopausal Korean women. Kim CJ, Oh KW, Rhee EJ, Kim KH, Jo SK, Jung CH, Won JC, Park CY, Lee WY, Park SW, Kim SW. Clin Endocrinol (Oxf); 2009 Jul; 71(1):18-26. PubMed ID: 19178508 [Abstract] [Full Text] [Related]
34. Difference in the relative contribution of lean and fat mass components to bone mineral density with generation. Mizuma N, Mizuma M, Yoshinaga M, Iwamoto I, Matsuo T, Douchi T, Osame M. J Obstet Gynaecol Res; 2006 Apr; 32(2):184-9. PubMed ID: 16594922 [Abstract] [Full Text] [Related]
35. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results. Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A. Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981 [Abstract] [Full Text] [Related]
36. Maternal weight and lean body mass may influence the lactation-related bone changes in young undernourished Indian women. Kulkarni B, Shatrugna V, Nagalla B, Ajeya Kumar P, Usha Rani K, Chandrakala Omkar A. Br J Nutr; 2009 May; 101(10):1527-33. PubMed ID: 18959808 [Abstract] [Full Text] [Related]
37. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients. Gerloni V, Pontikaki I, Gattinara M, Fantini F. Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916 [Abstract] [Full Text] [Related]
38. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG. Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903 [Abstract] [Full Text] [Related]
39. Gender differences in plasma ghrelin and its relations to body composition and bone - an opposite-sex twin study. Makovey J, Naganathan V, Seibel M, Sambrook P. Clin Endocrinol (Oxf); 2007 Apr; 66(4):530-7. PubMed ID: 17371471 [Abstract] [Full Text] [Related]
40. Cysteine, homocysteine and bone mineral density: a role for body composition? Elshorbagy AK, Gjesdal CG, Nurk E, Tell GS, Ueland PM, Nygård O, Tverdal A, Vollset SE, Smith AD, Refsum H. Bone; 2009 May; 44(5):954-8. PubMed ID: 19168166 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]